American Portfolios Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
American Portfolios Advisors's IBB Position: Q3 2022 in Review
American Portfolios Advisors reduced its iShares Biotechnology ETF (IBB) stake by 6% in Q3 2022, selling an estimated $97.9K and leaving 12,291 shares worth $1.44M. The position accounts for 0.06% of the portfolio, ranked #317.
American Portfolios Advisors first reported a position in IBB in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.54M in Q4 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.
- American Portfolios Advisors held 12,291 shares of iShares Biotechnology ETF worth $1.44M as of Q3 2022.
- American Portfolios Advisors sold 788 iShares Biotechnology ETF shares in Q3 2022, an estimated $97.9K.
- iShares Biotechnology ETF made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #317 holding.
- American Portfolios Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's iShares Biotechnology ETF position peaked at $2.54M in Q4 2021.
- 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.